GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently becoming a prominent focus in medical investigation, largely due to its remarkable impact on controlling diseases such as second type diabetes and weight gain. Ongoing studies have demonstrated that beyond glucose regulation, GLP-1 agonists offer promise for circulatory functi